OptiNose Inc. priced a public offering of 5 million common shares at $22.25 per share.
The Yardley, Pa.-based specialty pharmaceutical company is offering 2.5 million shares while certain selling stockholders are offering an equal number of shares. The company will raise net proceeds of about $52.3 million, and the stockholders will raise the same amount.
Underwriters have a 30-day option to buy up to an additional 750,000 shares at the offering price.
The offering, which is subject to customary closing conditions, is expected to close on or about June 11.
Jefferies and Piper Jaffray are serving as the lead book-running managers while BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers for the offering. Cantor is acting as sole lead manager.
